1 option
Harnessing the immune system for cancer therapy / Raghav Sundar.
- Format:
- Video
- Author/Creator:
- Sundar, Raghav, author.
- Language:
- English
- Subjects (All):
- Cancer--Treatment.
- Cancer.
- Immunological adjuvants.
- Physical Description:
- 1 online resource (1 streaming video file (40 min.))
- Place of Publication:
- London : Henry Stewart Talks, 2025.
- System Details:
- video file
- Contents:
- Introduction
- Disclosures
- What this talk will cover
- What this talk will not cover
- Lifetime chance of getting cancer
- UK cancer statistics
- Paradigm #1
- The beginnings of chemotherapy
- Advances in genomic biology has improved our understanding of cancer
- Understanding cancer pathways
- Early 2000s: targeted therapy era
- Acquired resistance to targeted therapy
- Hallmarks of cancer
- Germline mutations vs. somatic mutations
- Singapore's Mass Rapid Transport (MRT) map
- Bulk RNA sequencing
- Single cell RNA sequencing
- Spatial profiling
- Components of the TME
- History of immunotherapy evolution
- Steady state of an evolutionary arms race
- Checkpoint blockade
- Paradigm shift #1
- Paradigm #2
- Surgery for cancer therapy
- Surgery to 'cure' cancer
- Adjuvant and neoadjuvant therapy
- Total neoadjuvant therapy for rectal cancer
- Paradigm shift #2
- Paradigm #3
- Clinical case 1
- Clinical case 2
- MMR deficient colon cancer - KEYNOTE 177
- 1-, 5- and 10-year survival of most common cancers
- Paradigm shift #3
- Concluding remarks
- Thank you.
- Notes:
- Description based on publisher supplied metadata and other sources.
- Retrieved August 18, 2025, from https://doi.org/10.69645/JHNS2230.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.